Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Business Journal.
Press releases published on August 7, 2025
Rackspace Technology Reports Second Quarter 2025 Results
GlobeNewswire
·
August 7, 2025
Revenue of $666 million in the Second Quarter, down 3% Year-over-Year Private Cloud Revenue was $250 million, down 4% Year-over-Year Public Cloud Revenue was $417 million, down 2% Year-over-Year Second Quarter 2025 Cash Flow From Operating Activities was $ …
Bridger Aerospace Announces Strongest Second Quarter in Company History
GlobeNewswire
·
August 7, 2025
BELGRADE, Mont., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today reported record results for …
Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Q2 2025 product sales of $18.9 million, representing 108% growth over Q2 2024 and the 18th straight quarter of sequential product sales growth Q2 2025 basic and fully diluted GAAP EPS of $(0.10), non-GAAP fully diluted EPS of $0.03, and Adjusted EBITDA of …
BeautyHealth Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Raises guidance on strong execution and disciplined cost management Advances science-backed innovation with successful launch of the HydraFillic with Pep9™ Booster LONG BEACH, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: …
RxSight, Inc. Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
ALISO VIEJO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for …
Ventyx Biosciences Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Progress
GlobeNewswire
·
August 7, 2025
Positive topline Phase 2a biomarker data position VTX3232 as a potential disease-modifying therapy for patients with Parkinson’s disease Data from the Phase 2 study of VTX2735 in patients with recurrent pericarditis expected in Q4 2025 Phase 2 study of …
PureCycle Technologies Second Quarter 2025 Corporate Update
GlobeNewswire
·
August 7, 2025
ORLANDO, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. (Nasdaq: PCT), a U.S.-based company revolutionizing plastic recycling, announced today a corporate update for the second quarter ending June 30, 2025. Management Commentary …
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 7, 2025
CONSHOHOCKEN, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …
Fidus Investment Corporation Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Board of Directors Declared Total Dividends of $0.57 per Share for Third Quarter 2025 Base Dividend of $0.43 and Supplemental Dividend of $0.14 Per Share EVANSTON, Ill., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” …
89bio Reports Second Quarter 2025 Financial Results and Corporate Updates
GlobeNewswire
·
August 7, 2025
– ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis Phase 3 topline histology data expected in 1H 2027 and in 2028, respectively; each trial designed to support accelerated approval to treat patients with metabolic dysfunction-associated steatohepatitis (MASH) – …
Apyx Medical Expands Global Sales Leadership with Strategic Hires to Support AYON Launch and Accelerated Growth
GlobeNewswire
·
August 7, 2025
CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation, an advanced energy technology company and manufacturer of Renuvion® and the newly launched AYON Body Contouring System™, today announced the strategic appointments of two …
Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
CANTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …
Century Aluminum Company Reports Second Quarter 2025 Results
GlobeNewswire
·
August 7, 2025
CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its second quarter 2025 results. Second Quarter 2025 Financial Results $MM (except shipments and per share data) Q2 2025 Q1 2025 Aluminum shipments ( …
Relmada Therapeutics Reports Second Quarter 2025 Financial Results and Announces NDV-01 6-Month Follow-up Safety and Efficacy Data in NMIBC
GlobeNewswire
·
August 7, 2025
6-month follow-up for NDV-01 showed a 91% overall response rate at any time in non-muscle invasive bladder cancer, with good overall safety Enrollment in the Phase 2 study for NDV-01 continues, with updates expected at 9 and 12 month data follow-up. …
Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
GlobeNewswire
·
August 7, 2025
MENLO PARK, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform …
AvePoint Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Total quarterly revenue surpassed $100 million for the first time Second quarter SaaS revenue of $77.3 million, representing 44% year-over-year growth, 40% on a constant currency basis Second quarter Total revenue of $102.0 million, representing 31% year- …
Fractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
GlobeNewswire
·
August 7, 2025
Offering included participation from leading institutional investors, including Nantahala Capital, ADAR1 Capital Management, Second Line Capital, 683 Capital, and SilverArc Capital Proceeds expected to extend cash runway through key upcoming 3-and 6-month …
Synaptics Reports Fourth Quarter and Full Year Fiscal 2025 Results
GlobeNewswire
·
August 7, 2025
Fiscal 2025 revenue grew 12.0%, fueled by 53% growth in Core IoT product sales Synaptics' Board of Directors approved a new share repurchase program of up to $150 million Fiscal 2025 Financial Highlights Revenue of $1.074 billion increased 12% year-over- …
VAALCO Energy, Inc. Declares Third Quarter 2025 Dividend
GlobeNewswire
·
August 7, 2025
HOUSTON, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Vaalco Energy, Inc. (NYSE: EGY; LSE: EGY) (“Vaalco” or the “Company”) today announced that it declared its quarterly cash dividend of $0.0625 per share of common stock for the third quarter of 2025 ($0.25 …
Inseego Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Q2 2025 revenue of $40.2 million Q2 2025 Adjusted EBITDA of $4.7 million and GAAP Net Income of $0.5 million Paid off $14.9 million balance of 2025 Convertible Notes Entered into a $15.0 million undrawn working capital facility for further operating …